Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 4, 2014, Pages 860-869

  Nguyen, Nam ^a   de Esch, Celine ^a,c   Cameron, Barbara ^a   Kumar, Rakesh K ^a   Zekry, Amany ^a,b   Lloyd, Andrew R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chemokines; Leukocytes; Lobules; Portal tracts; Trafficking

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CXCL13 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; RANTES;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; B LYMPHOCYTE; CD20+ B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LEUKOCYTE; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER FIBROSIS; LYMPHOCYTIC INFILTRATION; MALE; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CHEMOKINES; LEUKOCYTES; LOBULES; PORTAL TRACTS; TRAFFICKING;

ADULT; ANTIGENS, CD; CHEMOKINES; FEMALE; GENE EXPRESSION; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; RECEPTORS, CCR5; RECEPTORS, CXCR3; RECEPTORS, CXCR5; T-LYMPHOCYTE SUBSETS;

EID: 84896334634     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12462     Document Type: Article

References (46)

1. Freeman AJ, Marinos G, Ffrench RA, Lloyd AR. Immunopathogenesis of hepatitis C virus infection. Immunol. Cell Biol. 2001; 79: 515-536.
2. Scheuer PJ, Krawczynski K, Dhillon AP. Histopathology and detection of hepatitis C virus in liver. Springer Semin. Immunopathol. 1997; 19: 27-45.
3. Khakoo SI, Soni PN, Savage K etal. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity. Am. J. Pathol. 1997; 150: 963-970.
4. Lalor PF, Shields P, Grant A, Adams DH. Recruitment of lymphocytes to the human liver. Immunol. Cell Biol. 2002; 80: 52-64.
5. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 60-66.
6. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 1992; 10: 561-591.
7. Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin. Immunopathol. 2009; 31: 309-322.
8. Apolinario A, Diago M, Lo Iacono O etal. Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy. Aliment. Pharmacol. Ther. 2004; 19: 551-562.
9. Apolinario A, Majano PL, Alvarez-Perez E etal. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am. J. Gastroenterol. 2002; 97: 2861-2870.
10. Harvey CE, Post JJ, Palladinetti P etal. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J. Leukoc. Biol. 2003; 74: 360-369.
11. Helbig KJ, Ruszkiewicz A, Semendric L, Harley HA, McColl SR, Beard MR. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 2004; 39: 1220-1229.
12. Narumi S, Tominaga Y, Tamaru M etal. Expression of IFN-inducible protein-10 in chronic hepatitis. J. Immunol. 1997; 158: 5536-5544.
13. Nishioji K, Okanoue T, Itoh Y etal. Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin. Exp. Immunol. 2001; 123: 271-279.
14. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J. Immunol. 1999; 163: 6236-6243.
15. Zeremski M, Petrovic LM, Chiriboga L etal. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 2008; 48: 1440-1450.
16. Bieche I, Asselah T, Laurendeau I etal. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005; 332: 130-144.
17. Kusano F, Tanaka Y, Marumo F, Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab. Invest. 2000; 80: 415-422.
18. Leifeld L, Dumoulin FL, Purr I etal. Early up-regulation of chemokine expression in fulminant hepatic failure. J. Pathol. 2003; 199: 335-344.
19. Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J. Viral Hepat. 2007; 14: 675-687.
20. Palmer C, Corpuz T, Guirguis M etal. The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection. Gut 2010; 59: 397-404.
21. Neuman MG, Benhamou JP, Marcellin P etal. Cytokine-chemokine and apoptotic signatures in patients with hepatitis C. Transl. Res. 2007; 149: 126-136.
22. Wald O, Weiss ID, Galun E, Peled A. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics. Cytokine 2007; 39: 50-62.
23. Boisvert J, Kunkel EJ, Campbell JJ, Keeffe EB, Butcher EC, Greenberg HB. Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J. Hepatol. 2003; 38: 67-75.
24. Efsen E, Grappone C, DeFranco RM etal. Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J. Hepatol. 2002; 37: 39-47.
25. Wald O, Pappo O, Safadi R etal. Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur. J. Immunol. 2004; 34: 1164-1174.
26. Heydtmann M, Lalor P, Eksteen B, Hubscher SG, Briskin M, Adams DH. CXCL chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J. Immunol. 2005; 174: 1055-1062.
27. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567-571.
28. Murakami J, Shimizu Y, Kashii Y etal. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology 1999; 30: 143-150.
29. Walewska-Zielecka B, Madalinski K, Jablonska J, Godzik P, Cielecka-Kuszyk J, Litwinska B. Composition of inflammatory infiltrate and its correlation with HBV/HCV antigen expression. World J. Gastroenterol. 2008; 14: 4040-4046.
30. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098-2102.
31. Junt T, Scandella E, Ludewig B. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat. Rev. Immunol. 2008; 8: 764-775.
32. Sansonno D, Tucci FA, Troiani L etal. Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis. Blood 2008; 112: 1620-1627.
33. Agnello V. Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective. Hepatology 1997; 26: 1375-1379.
34. Mihm S, Schweyer S, Ramadori G. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J. Med. Virol. 2003; 70: 562-570.
35. Wang J, Holmes TH, Cheung R, Greenberg HB, He XS. Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation. J. Infect. Dis. 2004; 190: 989-997.
36. Nischalke HD, Natterman J, Fischer HP, Sauerbruch T, Spengler U, Dumoulin FL. Semiquantitative analysis of intrahepatic CC-chemokine mRNAs in chronic hepatitis C. Mediators Inflamm. 2004; 13: 357-359.
37. Larrubia JR, Calvino M, Benito S etal. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection. J. Hepatol. 2007; 47: 632-641.
38. Canchis PW, Yee HT, Fiel MI etal. Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients. J. Acquir. Immune Defic. Syndr. 2004; 37: 1125-1131.
39. Freeman AJ, Pan Y, Harvey CE etal. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J. Hepatol. 2003; 38: 349-356.
40. Willberg CB, Ward SM, Clayton RF etal. Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha. PLoS ONE 2007; 2: e791.
41. Leroy V, Vigan I, Mosnier JF etal. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 2003; 38: 829-841.
42. Pham BN, Martinot-Peignoux M, Mosnier JF etal. CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C. Clin. Exp. Immunol. 1995; 102: 320-327.
43. Tran A, Yang G, Doglio A etal. Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C. Dig. Dis. Sci. 1997; 42: 2495-2500.
44. Kuntzen T, Tural C, Li B etal. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART. AIDS 2008; 22: 203-210.
45. Spengler U, Nattermann J. Immunopathogenesis in hepatitis C virus cirrhosis. Clin. Sci. (Lond) 2007; 112: 141-155.
46. Okada T, Ngo VN, Ekland EH etal. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 2002; 196: 65-75.